To Present at Jefferies 2015 Conference

RNS Number : 1029E
PureTech Health PLC
02 November 2015
 



 

 

 

 

2 November 2015

 

PureTech Health plc

 

PureTech Health to Present at Jefferies 2015 Global Healthcare Conference

 

PureTech Health plc ("PureTech" or the "Company", LSE: PRTC), a cross-disciplinary healthcare company, developing innovative products that could potentially improve the lives of billions of patients, will be presenting at the Jefferies 2015 Global Healthcare Conference to be held in London, 18-19 November 2015.

 

Daphne Zohar, PureTech Founder and CEO, will present on Wednesday, 18 November at 14.00 GMT.

 

About PureTech Health

PureTech Health (PureTech Health plc, PRTC.L) is a cross-disciplinary healthcare company, developing innovative products that could potentially improve the lives of billions of patients. PureTech has a pipeline of 12 operating companies, seven of which are "growth stage" with external validation including strategic partnerships, outside funding, proof-of-concept and/or peer review in prestigious scientific journals. PureTech also has a pipeline of ten "concept phase" initiatives resulting from review of more than 650 ideas annually. PureTech is focused on areas including immune and inflammatory disorders; cognitive and psychiatric disorders; diabetes and obesity; oncology; and infectious diseases, and has over 110 patents and patent applications. PureTech's leading team and board, along with an advisory network of more than 50 expert founder-scientists and advisors across multiple disciplines, gives PureTech access to potentially ground-breaking science and technological innovation. For more information, visit www.puretechhealth.com and connect with us on Twitter.

 

###

 

 

 

Enquiries:

 

PureTech

Julie DiCarlo, Senior Vice President, Communications and Investor Relations

 

+1 617 226 4819  

FTI Consulting (Communications adviser to PureTech)

Ben Atwell

Matthew Cole

+44 (0) 20 3727 1000

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAWGGPAUUPAGQU
UK 100

Latest directors dealings